Norges Bank Genetron Holdings LTD Transaction History

Norges Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.77 - $0.97 $278,645 - $351,020	-361,877 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$0.87 - $1.04 $137,222 - $164,036	157,727 New	157,727 $146,000
Q2 2023 Aug 14, 2023	SELL	$0.87 - $1.04 $444,347 - $531,173	-510,744 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$0.91 - $1.23 $198,649 - $268,504	218,296 New	218,296 $229,000
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $174,636 - $244,491	218,296 New	218,296 $244,000
Q3 2022 Nov 13, 2023	BUY	$0.91 - $1.69 $329,308 - $611,572	361,877 New	361,877 $329,000
Q2 2022 Aug 14, 2023	BUY	$1.28 - $2.4 $653,752 - $1.23 Million	510,744 New	510,744 $868,000
Q1 2022 May 12, 2023	BUY	$2.19 - $6.09 $640,461 - $1.78 Million	292,448 Added 133.97%	510,744 $1.12 Million
Q1 2022 May 09, 2022	SELL	$2.19 - $6.09 $218,345 - $607,179	-99,701 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$5.81 - $14.39 $579,262 - $1.43 Million	99,701 New	99,701 $608,000
Q3 2021 Nov 14, 2022	BUY	$11.55 - $20.3 $3.37 Million - $5.92 Million	291,721 New	291,721 $4.04 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.